Fig. 1From: Apatinib treatment efficiently delays biochemical-only recurrent ovarian cancer progressionKaplan-Meyer survival curve for estimating progression-free survival (PFS) in overall population (A), patients with biochemical relapse (B) and patients with apatinib monotherapy (C)Back to article page